Your browser doesn't support javascript.
loading
Monitoring KAT6A-CREBBP measurable residual disease in t(8;16) therapy-related acute myeloid leukemia.
Bhreathnach, Úna; Doherty, Dearbhla; Murphy, Karen; Flynn, Catherine M; Langabeer, Stephen E.
Afiliação
  • Bhreathnach Ú; Cancer Molecular Diagnostics, St. James's Hospital, Dublin D08 W9RT, Ireland.
  • Doherty D; Department of Haematology, St. Vincent's University Hospital, Dublin D04 T6F4, Ireland.
  • Murphy K; Department of Haematology, St. Vincent's University Hospital, Dublin D04 T6F4, Ireland.
  • Flynn CM; Department of Haematology, St. James's Hospital, Dublin D08 RX0X, Ireland.
  • Langabeer SE; Cancer Molecular Diagnostics, St. James's Hospital, Dublin D08 W9RT, Ireland. Electronic address: slangabeer@stjames.ie.
Leuk Res ; 116: 106823, 2022 05.
Article em En | MEDLINE | ID: mdl-35303627
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article